Balakrishnan Arpita, Winiarek Gabriela, Hołówka Olga, Godlewski Jakub, Bronisz Agnieszka
Tumor Microenvironment Laboratory, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.
Translational Medicine Doctoral School, Centre of Postgraduate Medical Education, Warsaw, Poland.
Front Immunol. 2025 Jan 29;16:1540431. doi: 10.3389/fimmu.2025.1540431. eCollection 2025.
The immunopeptidome, a diverse set of peptides presented by Major Histocompatibility Complex (MHC) molecules, is a critical component of immune recognition and response. This review article delves into the mechanisms of peptide presentation by MHC molecules, particularly emphasizing the roles of ncRNA-derived peptides and extracellular vesicles (EVs) in shaping the immunopeptidome landscape. We explore established and emerging insights into MHC molecule interactions with peptides, including the dynamics of peptide loading, transport, and the influence of cellular and genetic variations. The article highlights novel research on non-coding RNA (ncRNA)-derived peptides, which challenge conventional views of antigen processing and presentation and the role of EVs in transporting these peptides, thereby modulating immune responses at remote body sites. This novel research not only challenges conventional views but also opens up new avenues for understanding immune responses. Furthermore, we discuss the implications of these mechanisms in developing therapeutic strategies, particularly for cancer immunotherapy. By conducting a comprehensive analysis of current literature and advanced methodologies in immunopeptidomics, this review aims to deepen the understanding of the complex interplay between MHC peptide presentation and the immune system, offering new perspectives on potential diagnostic and therapeutic applications. Additionally, the interactions between ncRNA-derived peptides and EVs provide a mechanism for the enhanced surface presentation of these peptides and highlight a novel pathway for their systemic distribution, potentially altering immune surveillance and therapeutic landscapes.
免疫肽组是由主要组织相容性复合体(MHC)分子呈递的一组多样的肽,是免疫识别和反应的关键组成部分。这篇综述文章深入探讨了MHC分子呈递肽的机制,特别强调了非编码RNA衍生肽和细胞外囊泡(EV)在塑造免疫肽组格局中的作用。我们探索了关于MHC分子与肽相互作用的既有和新出现的见解,包括肽加载、运输的动态过程以及细胞和遗传变异的影响。文章突出了关于非编码RNA(ncRNA)衍生肽的新研究,这些研究挑战了抗原加工和呈递的传统观点以及EV在运输这些肽从而调节远端身体部位免疫反应中的作用。这项新研究不仅挑战了传统观点,还为理解免疫反应开辟了新途径。此外,我们讨论了这些机制在制定治疗策略,特别是癌症免疫治疗策略中的意义。通过对免疫肽组学的当前文献和先进方法进行全面分析,本综述旨在加深对MHC肽呈递与免疫系统之间复杂相互作用的理解,为潜在的诊断和治疗应用提供新视角。此外,ncRNA衍生肽与EV之间的相互作用为这些肽的增强表面呈递提供了一种机制,并突出了它们全身分布的新途径,可能改变免疫监视和治疗格局。